InvestorsHub Logo

Hike

10/31/14 3:09 PM

#132679 RE: Hike #132677

So for me I'll use the $7 billion US market figure.

Assuming say 30% of that market is Abuse Deterrent three years from now based on a phasing in of ART/ADT rather than the FDA hitting the switch and mandating across the board.

So now it's $2.1 billion market opportunity three years from now.

Now let's assume Elite gets a 10% share of that market.
That's $210,000,000 in sales.

That is oh, about 50 times their current sales figure that supports a price of .32/share.

So, this is still looking mighty good to me!

John_Langston

10/31/14 6:45 PM

#132705 RE: Hike #132677

So...11.7 to 14.8 billion not 20 billion; thanks for clearing up the misinformation.